Value Antiproteinuric Effects From Vitamin D Derivatives in Patient With Chronic Kidney Illness and the Lack of Vitamin D

A phase 4 trial registered on ClinicalTrials.gov. The registry status is unknown. It plans to enroll 174 participants.

Also called NCT01442272

  • Study
  • In this atlas

Overview

Design
Interventional study; randomized; no masking; primary purpose treatment
Phase
Phase 4
Enrolled
  • 174 participants (planned count) (from the registry)
Sponsor
Hospital Universitario de Canarias (from the registry)
Registry
  • NCT NCT01442272
Start date
(registry gives no type) (from the registry)
Primary completion
(anticipated) (from the registry)
Completion
(anticipated) (from the registry)
Countries
Spain (from the registry)
Registry status
  • Unknown status (from the registry)

Technical summary

Registry record NCT01442272. Randomized; no masking; primary purpose treatment. Start 2012-01 (registry gives no type); primary completion 2012-10 (anticipated). Results not posted.

The registry's words

Labels as the registry gives them, not rewritten.

Brief title
Value Antiproteinuric Effects From Vitamin D Derivatives in Patient With Chronic Kidney Illness and the Lack of Vitamin D
Acronym
NEFROVID2010
Condition
Kidney Failure, Chronic
Condition
Disorder of Vitamin D
Intervention (Drug)
Hidroferol®
Intervention (Drug)
Paricalcitol: Zemplar®
Intervention (Drug)
Habitual medication
Lead sponsor
Hospital Universitario de Canarias (class: other)

Record details

Record id
cardio:ct-nct01442272
Content hash
e55b265873081dc2460c88d6fcafbca3d1120dcaedd140b1b03c1441d83b0d8a